• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Geron Corporation - Common Stock (NQ:GERN)

    1.240 -0.020 (-1.59%)
    Streaming Delayed Price Updated: 10:51 AM EDT, Sep 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,575,837
    Open 1.270
    Bid (Size) 1.230 (21,400)
    Ask (Size) 1.240 (21,300)
    Prev. Close 1.260
    Today's Range 1.220 - 1.270
    52wk Range 1.040 - 2.010
    Shares Outstanding 508,766,846
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Geron Eyes High End of 2026 RYTELO Revenue Guidance as Community Adoption Expands ↗
    Geron (NASDAQ:GERN) executives said the company remains on track to generate 2026 RYTELO net revenue of $220 million to $240 million, with Chief Executive Officer Harout Semerjian saying the company... 
    Via MarketBeat
    News headline image
    Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN
    From Kahn Swick & Foti, LLC
    Via Business Wire

    Performance

    YTD
    -6.1%
    -6.1%
    1 Month
    -17.9%
    -17.9%
    3 Month
    -4.6%
    -4.6%
    6 Month
    -12.1%
    -12.1%
    1 Year
    -5.3%
    -5.3%

    More News

    Read More
    News headline image
    Geron Sees RYTELO Revenue Near High End of 2026 Guidance as Community Use Expands ↗
    Via MarketBeat
    Geron (NASDAQ:GERN) Falls After Mixed Q2 Results; Revenue Beats but Loss Wider Than Expected ↗
    Via Chartmill
    Geron Corp. (NASDAQ:GERN) Beats Q1 Estimates as RYTELO Sales Momentum Continues ↗
    Via Chartmill
    Geron Corp (NASDAQ:GERN) Stock Plummets 10% After Q4 Revenue Miss ↗
    Via Chartmill
    News headline image
    Earnings Scheduled For November 5, 2025 ↗
    Via Benzinga
    News headline image
    Geron Earnings Preview ↗
    Via Benzinga
    News headline image
    Geron (GERN) Q2 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Geron Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets
    Via FinancialNewsMedia
    News headline image
    Geron (GERN) Q1 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings Economy
    News headline image
    Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone
    Via FinancialNewsMedia
    Here are the top movers in Wednesday's session. ↗
    Via Chartmill
    News headline image
    Geron (GERN) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    Which stocks are moving before the opening bell on Wednesday? ↗
    Via Chartmill
    News headline image
    Why Did GERN Stock Tumble 10% Pre-Market Today? ↗
    Via Stocktwits
    Topics Artificial Intelligence
    News headline image
    Geron Corp (NASDAQ:GERN) Reports Mixed Q3 2025 Results, Misses Revenue Estimates ↗
    Via Chartmill
    News headline image
    Geron Corporation Reports Third Quarter 2025 Financial Results and Recent Business Highlights
    From Geron Corporation
    Via Business Wire
    News headline image
    Geron Corporation to Present at Upcoming Investor Conferences
    From Geron Corporation
    Via Business Wire
    News headline image
    Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies
    From Geron Corporation
    Via Business Wire
    News headline image
    Geron Plans to Announce Third Quarter 2025 Financial Results on November 5, 2025
    From Geron Corporation
    Via Business Wire
    News headline image
    GERON (GERN) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Geron Corporation
    Via Business Wire
    News headline image
    Geron to Participate in the 2025 Wells Fargo Healthcare Conference
    From Geron Corporation
    Via Business Wire

    Frequently Asked Questions

    Is Geron Corporation - Common Stock publicly traded?
    Yes, Geron Corporation - Common Stock is publicly traded.
    What exchange does Geron Corporation - Common Stock trade on?
    Geron Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Geron Corporation - Common Stock?
    The ticker symbol for Geron Corporation - Common Stock is GERN on the Nasdaq Stock Market
    What is the current price of Geron Corporation - Common Stock?
    The current price of Geron Corporation - Common Stock is 1.240
    When was Geron Corporation - Common Stock last traded?
    The last trade of Geron Corporation - Common Stock was at 09/28/26 10:51 AM ET
    What is the market capitalization of Geron Corporation - Common Stock?
    The market capitalization of Geron Corporation - Common Stock is 630.87M
    How many shares of Geron Corporation - Common Stock are outstanding?
    Geron Corporation - Common Stock has 631M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.